The regulatory mechanism of β-eudesmol is through the suppression of caspase-1 activation in mast cell-mediated inflammatory response

Immunopharmacology and Immunotoxicology

Volumn 33, Issue 1, 2011, Pages 178-185

  Seo, Min Jun ^a   Kim, Su Jin ^b   Kang, Tae Hee ^b   Rim, Hong Kun ^b   Jeong, Hyun Ja ^c   Um, Jae Young ^b   Hong, Seung Heon ^d   Kim, Hyung Min ^b  

^a Gyeongju University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Hoseo University   (South Korea)

^d Wonkwang University   (South Korea)

Author keywords

eudesmol; caspase 1; interlukin 6; mast cells; nuclear factor B

Indexed keywords

BETA EUDESMOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME REPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; CALCIMYCIN; CASPASE 1; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-6; MAST CELLS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SESQUITERPENES, EUDESMANE; TETRADECANOYLPHORBOL ACETATE;

ATRACTYLODES LANCEA;

EID: 79551579479     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2010.491082     Document Type: Article

References (40)

1. Holgate, S.T. Te role of mast cells and basophils in infammation. Clin. Exp. Allergy 2000, 30 Suppl 1, 28-32.
2. Gotis-Graham, I., Smith, M.D., Parker, A., McNeil, H.P. Synovial mast cell responses during clinical improvement in early rheu-matoid arthritis. Ann. Rheum. Dis. 1998, 57, 664-71.
3. Echtenacher, B., Männel, D.N., Hültner, L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996, 381, 75-7.
4. Church, M.K., Levi-Schafer, F. Te human mast cell. J. Allergy Clin. Immunol. 1997, 99, 155-60.
5. Metcalfe, D.D., Baram, D., Mekori, Y.A. Mast cells. Physiol. Rev. 1997, 77, 1033-79.
6. Totaro, R., Passacantando, A., Russo, T., Parzanese, I., Rascente, M., Marini, C, Tonietti, G., Carolei, A. Efects of interferon beta, cyclo-phosphamide and azathioprine on cytokine profle in patients with multiple sclerosis. Int. J. Immunopathol. Pharmacol. 2005, 18, 377-83.
7. Cross, M.L. Immune-signalling by orally-delivered probiotic bac-teria: efects on common mucosal immunoresponses and pro-tection at distal mucosal sites. Int. J. Immunopathol. Pharmacol. 2004, 17, 127-34.
8. Sardella, G., Accapezzato, D., Di Roma, A., Iacoboni, C, Francavilla, V., Benedetti, G., Musto, C, Fedele, F., Bruno, G., Paroli, M. Integrin beta2-chain (CD18) over-expression on CD4+ T cells and monocytes after ischemia/reperfusion in patients undergoing primary percutaneous revascularization. Int. J. Immunopathol. Pharmacol. 2004, 17, 165-70.
9. Di Pietro, R., Centurione, L., Sabatini, N., Bosco, D., Sancilio, S., Garaci, F., Rana, R., Cataldi, A. Caspase-3 is dually regulated by apoptogenic factors mitochondrial release and by SAPK/JNK metabolic pathway in leukemic cells exposed to etoposide-ionizing radiation combined treatment. Int. J. Immunopathol. Pharmacol. 2004, 17, 181-90.
10. Cobb, M.H., Goldsmith, E.J. Dimerization in MAP-kinase signal-ing. Trends Biochem. Sci. 2000, 25, 7-9.
11. Lewis, T.S., Shapiro, P.S., Ahn, N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 1998, 74, 49-139.
12. Ono, K., Han, J. Te p38 signal transduction pathway: activation and function. Cell. Signal. 2000, 12, 1-13.
13. Lee, S.H., Stehlik, C, Reed, J.C. Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J. Biol. Chem. 2001, 276, 34495-500.
14. Wang, X., Wang, H., Figueroa, B.E., Zhang, W.H., Huo, C, Guan, Y., Zhang, Y, Bruey, J.M., Reed, J.C., Friedlander, R.M. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington's disease. J. Neurosci. 2005, 25, 11645-54.
15. Druilhe, A., Srinivasula, S.M., Razmara, M., Ahmad, M., Alnemri, E.S. Regulation of IL-1beta generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Difer. 2001, 8, 649-57.
16. Srinivasula, S.M., Poyet, J.L., Razmara, M., Datta, P., Zhang, Z., Alnemri, E.S. Te PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J. Biol. Chem. 2002, 277, 21119-22.
17. Stehlik, C, Lee, S.H., Dorfeutner, A., Stassinopoulos, A., Sagara, J., Reed, J.C. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J. Immunol. 2003, 171, 6154-63.
18. Mariathasan, S., Newton, K., Monack, D.M., Vucic, D., French, D.M., Lee, W.P., Roose-Girma, M., Erickson, S., Dixit, V.M. Diferential activation of the infammasome by caspase-1 adap-tors ASC and Ipaf. Nature 2004, 430, 213-8.
19. Jason, G.W., Pajurkova, E.M., Suchowersky, O., Hewitt, J., Hilbert, C, Reed, J., Hayden, M.R. Presymptomatic neuropsy-chological impairment in Huntington's disease. Arch. Neurol. 1988, 45, 769-73.
20. Poyet, J.L., Srinivasula, S.M., Tnani, M., Razmara, M., Fernandes-Alnemri, T., Alnemri, E.S. Identifcation of Ipaf, a human caspase-1-activating protein related to Apaf-1. J. Biol. Chem. 2001, 276, 28309-13.
21. Humke, E.W., Shriver, S.K., Starovasnik, M.A., Fairbrother, W.J., Dixit, V.M. ICEBERG: a novel inhibitor of interleukin-1beta gen-eration. Cell 2000, 103, 99-111.
22. Kimura, M., Kimura, I., Kondoh, T., Tsuneki, H. Noncontractile acetylcholine receptor-operated Ca++ mobilization: suppres-sion of activation by open channel blockers and acceleration of desensitization by closed channel blockers in mouse diaphragm muscle. J. Pharmacol. Exp. Ter. 1991, 256, 18-23.
23. Kimura, M., Nojima, H., Muroi, M., Kimura, I. Mechanism of the blocking action of beta-eudesmol on the nicotinic acetylcholine receptor channel in mouse skeletal muscles. Neuropharmacology 1991, 30, 835-41.
24. Tsuneki, H., Ma, E.L., Kobayashi, S., Sekizaki, N., Maekawa, K., Sasaoka, T., Wang, M.W., Kimura, I. Antiangiogenic activity of beta-eudesmol in vitro and in vivo. Eur. J. Pharmacol. 2005, 512, 105-15.
25. Schoonbroodt, S., Legrand-Poels, S., Best-Belpomme, M., Piette, J. Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem. J. 1997, 321 (Pt 3), 777-85.
26. Kimura, I. Antiangiogenic activity of beta-eudesmol in vitro and in vivo. Eur J Pharmacol 2005, 512, 105-115.
27. Obara, Y [Development of anti-dementia drugs related to neu-rotrophic factors]. Yakugaku Zasshi 2006, 126, 747-55.
28. Enerbäck, L., Pipkorn, U., Granerus, G. Intraepithelial migration of nasal mucosal mast cells in hay fever. Int. Arch. Allergy Appl. Immunol. 1986, 80, 44-51.
29. Laitinen, L.A., Laitinen, A., Haahtela, T. Airway mucosal infam-mation even in patients with newly diagnosed asthma. Am. Rev. Respir. Dis. 1993, 147, 697-704.
30. Marone, G. Mast cells in rheumatic disorders: mastermind or workhorse? Clin. Exp. Rheumatol. 1998, 16, 245-9.
31. Papanicolaou, D.A., Wilder, R.L., Manolagas, S.C., Chrousos, G.P. Te pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 1998, 128, 127-37.
32. Adwanikar, H., Karim, F., Gereau, R.W. Infammation per-sistently enhances nocifensive behaviors mediated by spinal group I mGluRs through sustained ERK activation. Pain 2004, 111, 125-35.
33. Jeong, H.J., Na, H.J., Hong, S.H., Kim, H.M. Inhibition of the stem cell factor-induced migration of mast cells by dexamethasone. Endocrinology 2003, 144, 4080-6.
34. Börsch-Haubold, A.G., Pasquet, S., Watson, S.P. Direct inhibition of cyclooxygenase-1 and-2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase. J. Biol. Chem. 1998, 273, 28766-72.
35. Kim, SJ., Jeong, HJ., Park, R.K., Lee, K.M., Kim, H.M., Um, J.Y., Hong, S.H. Te regulatory efect of SC-236 (4-[5-(4-chlorophenyl)-3-(trifuoromethyl)-1- pyrazol-1-l]benzenesulfonamide) on stem cell factor induced migration of mast cells. Toxicol. Appl. Pharmacol. 2007, 220, 138-45.
36. Koranteng, R.D., Swindle, E.J., Davis, B.J., Dearman, RJ., Kimber, I., Flanagan, B.F., Coleman, J.W. Diferential regula-tion of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580. Clin. Exp. Immunol. 2004, 137, 81-7.
37. Faubel, S., Lewis, E.C., Reznikov, L., Ljubanovic, D., Hoke, T.S., Somerset, H., Oh, DJ., Lu, L., Klein, C.L., Dinarello, C.A., Edelstein, C.L. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infltration in the kidney. J. Pharmacol. Exp. Ter. 2007, 322, 8-15.
38. Kuida, K., Lippke, J.A., Ku, G., Harding, M.W., Livingston, DJ., Su, M.S., Flavell, R.A. Altered cytokine export and apoptosis in mice defcient in interleukin-1 beta converting enzyme. Science 1995, 267, 2000-3.
39. Chin, A.I., Dempsey, P.W., Bruhn, K., Miller, J.F., Xu, Y., Cheng, G. Involvement of receptor-interacting protein 2 in innate and adap-tive immune responses. Nature 2002, 416, 190-4.
40. Kobayashi, K., Inohara, N., Hernandez, L.D., Galán, J.E., Núñez, G., Janeway, C.A., Medzhitov, R., Flavell, R.A. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002, 416, 194-9.